A Study Reviewing Medical Records to Learn More About Treat-and-extend With Eylea in Patients With Neovascular Age-related Macular Degeneration (nAMD).
Condition: Neovascular Age-related Macular Degeneration Intervention: Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) Sponsor: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Age-Related Macular Degeneration (AMD) | Learning | Research | Study | Universities & Medical Training